{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:03:04Z","timestamp":1790816584142,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05547-3","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:54:44Z","timestamp":1783432484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan cancer analyses and clinical cohort validation identify HOMER3 as colorectal cancer prognostic biomarker and therapeutic target"],"prefix":"10.1007","volume":"17","author":[{"given":"Hong-Chao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"5","key":"5547_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.neuint.2012.06.014","volume":"61","author":"P Luo","year":"2012","unstructured":"Luo P, et al. Scaffold protein Homer 1: implications for neurological diseases. Neurochem Int. 2012;61(5):731\u20138.","journal-title":"Neurochem Int"},{"issue":"3","key":"5547_CR2","doi-asserted-by":"publisher","first-page":"e1005137","DOI":"10.1371\/journal.pgen.1005137","volume":"11","author":"H Azaiez","year":"2015","unstructured":"Azaiez H, et al. HOMER2, a stereociliary scaffolding protein, is essential for normal hearing in humans and mice. PLoS Genet. 2015;11(3):e1005137.","journal-title":"PLoS Genet"},{"issue":"3","key":"5547_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"5547_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1089\/cmb.2018.0237","volume":"26","author":"Y Qi","year":"2019","unstructured":"Qi Y, et al. Bioinformatics analysis of key genes and pathways in colorectal cancer. J Comput Biol. 2019;26(4):364\u201375.","journal-title":"J Comput Biol"},{"issue":"1","key":"5547_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/0109298665248028231122064831","volume":"31","author":"Z Xu","year":"2024","unstructured":"Xu Z, et al. LINC01836 promotes colorectal cancer progression and functions as ceRNA to target SLC17A9 by sponging miR-1226-3p. Protein Pept Lett. 2024;31(1):43\u201360.","journal-title":"Protein Pept Lett"},{"key":"5547_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/1874467217666230915125622","volume":"17","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, et al. PF-04449913 inhibits proliferation and metastasis of colorectal cancer cells by down-regulating MMP9 expression through the ERK\/p65 pathway. Curr Mol Pharmacol. 2024;17:e150923221164.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"5547_CR7","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"5547_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/0109298665256238231120093150","volume":"31","author":"M Wu","year":"2024","unstructured":"Wu M, Wu X, Han J. KIF20A promotes CRC progression and the Warburg effect through the C-Myc\/HIF-1\u03b1 axis. Protein Pept Lett. 2024;31(2):107\u201315.","journal-title":"Protein Pept Lett"},{"issue":"6","key":"5547_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, et al. Circular RNA hsa_circ_0005939 regulates UHRF1BP1L expression by targeting miR-4693-3p to promote colorectal cancer progression. Protein Pept Lett. 2024;31(6):437\u201346.","journal-title":"Protein Pept Lett"},{"issue":"7","key":"5547_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, et al. miR-1204 positioning in 8q24.21 involved in the tumorigenesis of colorectal cancer by targeting MASPIN. Protein Pept Lett. 2024;31(7):544\u201358.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"5547_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/gb-2007-8-2-206","volume":"8","author":"Y Shiraishi-Yamaguchi","year":"2007","unstructured":"Shiraishi-Yamaguchi Y, Furuichi T. The Homer family proteins. Genome Biol. 2007;8(2):206.","journal-title":"Genome Biol"},{"issue":"9","key":"5547_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/iub.1198","volume":"65","author":"M Salanova","year":"2013","unstructured":"Salanova M, Volpe P, Blottner D. Homer protein family regulation in skeletal muscle and neuromuscular adaptation. IUBMB Life. 2013;65(9):769\u201376.","journal-title":"IUBMB Life"},{"issue":"1","key":"5547_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1471-4159.2012.07752.x","volume":"122","author":"K Rezvani","year":"2012","unstructured":"Rezvani K, et al. Proteasomal degradation of the metabotropic glutamate receptor 1\u03b1 is mediated by Homer-3 via the proteasomal S8 ATPase: signal transduction and synaptic transmission. J Neurochem. 2012;122(1):24\u201337.","journal-title":"J Neurochem"},{"issue":"8","key":"5547_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/153537020523000803","volume":"230","author":"RS Duncan","year":"2005","unstructured":"Duncan RS, Hwang S-Y, Koulen P. Effects of Vesl\/Homer proteins on intracellular signaling. Exp Biol Med. 2005;230(8):527\u201335.","journal-title":"Exp Biol Med"},{"issue":"12","key":"5547_CR15","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41419-023-06335-5","volume":"14","author":"T Sun","year":"2023","unstructured":"Sun T, et al. HOMER3 promotes non-small cell lung cancer growth and metastasis primarily through GABPB1-mediated mitochondrial metabolism. Cell Death Dis. 2023;14(12):814.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5547_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-020-01021-x","volume":"14","author":"Q Liu","year":"2021","unstructured":"Liu Q, et al. HOMER3 facilitates growth factor-mediated \u03b2-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer. J Hematol Oncol. 2021;14(1):6.","journal-title":"J Hematol Oncol"},{"issue":"41","key":"5547_CR17","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/s41388-025-03548-0","volume":"44","author":"T Tong","year":"2025","unstructured":"Tong T, et al. HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer. Oncogene. 2025;44(41):3895\u2013908.","journal-title":"Oncogene"},{"issue":"4","key":"5547_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jcps.2014.12.002","volume":"25","author":"D Iacobucci","year":"2015","unstructured":"Iacobucci D, et al. Toward a more nuanced understanding of the statistical properties of a median split. J Consumer Psychol. 2015;25(4):652\u201365.","journal-title":"J Consumer Psychol"},{"issue":"4","key":"5547_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jcps.2015.06.014","volume":"25","author":"D Iacobucci","year":"2015","unstructured":"Iacobucci D, et al. The median split: robust, refined, and revived. J Consumer Psychol. 2015;25(4):690\u2013704.","journal-title":"J Consumer Psychol"},{"issue":"7693","key":"5547_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"5","key":"5547_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","volume":"7","author":"D Zeng","year":"2019","unstructured":"Zeng D, et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol Res. 2019;7(5):737\u201350.","journal-title":"Cancer Immunol Res"},{"issue":"7693","key":"5547_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"key":"5547_CR23","first-page":"1","volume":"1","author":"R Bonneville","year":"2017","unstructured":"Bonneville R, et al. Landscape of microsatellite instability across 39 cancer types. JCO Prec Oncol. 2017;1:1\u201315.","journal-title":"JCO Prec Oncol"},{"issue":"15suppl","key":"5547_CR24","doi-asserted-by":"publisher","first-page":"e15169","DOI":"10.1200\/JCO.2020.38.15_suppl.e15169","volume":"38","author":"Z ZHAO","year":"2020","unstructured":"ZHAO Z, et al. Correlation between TMB and MSI in patients with solid tumors. J Clin Oncol. 2020;38(15suppl):e15169\u201315169.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5547_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri M, et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 2022;7(1):100336.","journal-title":"ESMO Open"},{"issue":"1","key":"5547_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13062-025-00643-w","volume":"20","author":"F Wang","year":"2025","unstructured":"Wang F, et al. ELK4 induced upregulation of HOMER3 promotes the proliferation and metastasis in glioma via Wnt\/\u03b2-catenin\/EMT signaling pathway. Biol Direct. 2025;20(1):48.","journal-title":"Biol Direct"},{"issue":"9","key":"5547_CR27","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1091\/mbc.E14-07-1197","volume":"26","author":"J Wu","year":"2015","unstructured":"Wu J, et al. Homer3 regulates the establishment of neutrophil polarity. Mol Biol Cell. 2015;26(9):1629\u201339.","journal-title":"Mol Biol Cell"},{"issue":"12","key":"5547_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41419-023-06335-5","volume":"14","author":"T Sun","year":"2023","unstructured":"Sun T, et al. HOMER3 promotes non-small cell lung cancer growth and metastasis primarily through GABPB1-mediated mitochondrial metabolism. Cell Death Dis. 2023;14(12):814.","journal-title":"Cell Death Dis"},{"issue":"8","key":"5547_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41401-020-00548-6","volume":"42","author":"Y-y Zhao","year":"2021","unstructured":"Zhao Y-y, et al. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K\/Akt\/mTOR and MEK\/ERK signaling pathways and blocking EMT. Acta Pharmacol Sin. 2021;42(8):1288\u201397.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"5547_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-021-01988-6","volume":"40","author":"A Peixoto","year":"2021","unstructured":"Peixoto A, et al. Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer. J Exp Clin Cancer Res. 2021;40(1):191.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"5547_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41388-025-03611-w","volume":"45","author":"C Xu","year":"2026","unstructured":"Xu C, et al. HOMER3 drives oral squamous cell carcinoma progression through TRPV6 calcium influx and TUBB3 microtubule stabilization. Oncogene. 2026;45(2):278\u201394.","journal-title":"Oncogene"},{"key":"5547_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-04247-8","author":"R Luan","year":"2025","unstructured":"Luan R, Yang C, Niu X. HOMER3 and its correlation with immune-infiltrating M2 macrophages in colorectal cancer. Discov Oncol. 2025. https:\/\/doi.org\/10.1007\/s12672-025-04247-8.","journal-title":"Discov Oncol"},{"issue":"16","key":"5547_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168470","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang H, Tian T, Zhang J. Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis. Int J Mol Sci. 2021;22(16):8470.","journal-title":"Int J Mol Sci"},{"key":"5547_CR34","volume-title":"Semin Cancer Biol","author":"TL Whiteside","year":"2012","unstructured":"Whiteside TL. What are regulatory T cells (Treg) regulating in cancer and why? In: Semin Cancer Biol. Elsevier; 2012."},{"issue":"4","key":"5547_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","volume":"70","author":"A Corthay","year":"2009","unstructured":"Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326\u201336.","journal-title":"Scand J Immunol"},{"issue":"7","key":"5547_CR36","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/cancers12071888","volume":"12","author":"JE Olguin","year":"2020","unstructured":"Olguin JE, et al. Relevance of regulatory T cells during colorectal cancer development. Cancers. 2020;12(7):1888.","journal-title":"Cancers"},{"issue":"4","key":"5547_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"5547_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S. NF-\u03baB in immunobiology. Cell Res. 2011;21(2):223\u201344.","journal-title":"Cell Res"},{"key":"5547_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1430310","volume":"12","author":"Y Jia","year":"2024","unstructured":"Jia Y, et al. PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer. Front Cell Dev Biol. 2024;12:1430310.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"5547_CR40","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/jamaoncol.2022.1981","volume":"8","author":"B Ricciuti","year":"2022","unstructured":"Ricciuti B, et al. Association of high tumor mutation burden in non\u2013small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels. JAMA Oncol. 2022;8(8):1160\u20138.","journal-title":"JAMA Oncol"},{"issue":"5","key":"5547_CR41","doi-asserted-by":"publisher","first-page":"e010486","DOI":"10.1136\/jitc-2024-010486","volume":"13","author":"M Zheng","year":"2025","unstructured":"Zheng M. Super-high tumor mutational burden predicts complete remission following immunotherapy: from Peto\u2019s paradox to druggable cancer hallmark. J Immunother Cancer. 2025;13(5):e010486.","journal-title":"J Immunother Cancer"},{"key":"5547_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.748674","author":"B Ning","year":"2022","unstructured":"Ning B, et al. The predictive value of tumor mutation burden on clinical efficacy of immune checkpoint inhibitors in melanoma: a systematic review and meta-analysis. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.748674.","journal-title":"Front Pharmacol"},{"issue":"12","key":"5547_CR43","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41589-023-01353-y","volume":"19","author":"X Li","year":"2023","unstructured":"Li X, et al. Polarized focal adhesion kinase activity within a focal adhesion during cell migration. Nat Chem Biol. 2023;19(12):1458\u201368.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"5547_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","volume":"12","author":"X Tan","year":"2023","unstructured":"Tan X, et al. Focal adhesion kinase: from biological functions to therapeutic strategies. Exp Hematol Oncol. 2023;12(1):83.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"5547_CR45","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3390\/ijms25031848","volume":"25","author":"D-T Morgos","year":"2024","unstructured":"Morgos D-T, et al. Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer. Int J Mol Sci. 2024;25(3):1848.","journal-title":"Int J Mol Sci"},{"key":"5547_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygyno.2023.01.038","volume":"171","author":"CSE Hendrikse","year":"2023","unstructured":"Hendrikse CSE, et al. The potential of RAS\/RAF\/MEK\/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol. 2023;171:83\u201394.","journal-title":"Gynecol Oncol"},{"key":"5547_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117323","volume":"319","author":"Y Wu","year":"2024","unstructured":"Wu Y, et al. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK\/p38 MAPK signaling pathway. J Ethnopharmacol. 2024;319:117323.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"5547_CR48","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1871520621666210402110331","volume":"22","author":"L Meng","year":"2022","unstructured":"Meng L, et al. Nilotinib, a tyrosine kinase inhibitor, suppresses the cell growth and triggers autophagy in papillary thyroid cancer. Anti Cancer Agents Med Chem. 2022;22(3):596\u2013602.","journal-title":"Anti Cancer Agents Med Chem"},{"key":"5547_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-12-802104-0.00014-7","volume-title":"Pharmacognosy","author":"M Shields","year":"2017","unstructured":"Shields M. Chap.\u00a014 - Chemotherapeutics. In: Badal S, Delgoda R, editors. Pharmacognosy. Boston: Academic Press; 2017. p. 295\u2013313."},{"issue":"1","key":"5547_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, et al. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23(1):108.","journal-title":"Mol Cancer"},{"key":"5547_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101851","volume":"40","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Anti-PD-1\/PD-L1 therapy for colorectal cancer: clinical implications and future considerations. Transl Oncol. 2024;40:101851.","journal-title":"Transl Oncol"},{"key":"5547_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116203","volume":"171","author":"J-W Cui","year":"2024","unstructured":"Cui J-W, et al. Tumor immunotherapy resistance: revealing the mechanism of PD-1 \/ PD-L1-mediated tumor immune escape. Biomed Pharmacother. 2024;171: 116203.","journal-title":"Biomed Pharmacother"},{"key":"5547_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2022.07.004","volume":"67","author":"W Li","year":"2022","unstructured":"Li W, et al. Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: a key player in tumor immunotherapy. Cytokine Growth Factor Rev. 2022;67:49\u201357.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"5547_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer. 2023;22(1):58.","journal-title":"Mol Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05547-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05547-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05547-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:30:09Z","timestamp":1790814609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05547-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5547"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05547-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Dalian University Affiliated Xinhua Hospital Ethics Committee (No. 2026-005-02) in accordance with the Declaration of Helsinki. Informed consent was obtained from all the individual participants for participation in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The publication of this article has been approved by all the authors.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is an original research achievement independently completed by the author. It has not been published in any form either domestically or internationally. All citations in the article have been properly marked.","order":3,"name":"Ethics","label":"Statement of non-duplication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1394"}}